CPH:CC News and Press, Cipher Pharmaceuticals Inc. From 05/12/22

Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial Results Canada NewsWire (All figures are in U.S. dollars) Drove 60% increase in EPS to $0.08 Demonstrated a focus on execution as EBITDA increased 38% to $3.1 million T...

Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , May 9, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Company ") today announced that  it will release its ...

Cipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North American Phase 3 Study Canada NewsWire MISSISSAUGA, ON , March 22, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Company ")...

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results Canada NewsWire Demonstrated growth in FY 2021 as EBITDA increased 46% to $11.8 million Disciplined cost structure led to an 18% reduction in SG&A 81% increase ...